Clinical Trial Update: A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS

View source ↗

Summary

This clinical trial update describes PERMEALS, a patient-tailored approach combining genetics, biomarkers, and induced pluripotent stem cells for amyotrophic la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Status: RECRUITING